FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- MEDNAX, Inc. (NYSE:MD), will host an investor conference call and Webcast on Tuesday, November 1, 2011, at 10:00 a.m. Eastern Time, to discuss results from operations for the three months and nine months ended September 30, 2011. A detailed press release will be issued the morning of November 1, 2011, before the securities markets open.

The investor conference call will be Webcast and may be accessed at MEDNAX’s Website, www.mednax.com.

ABOUT MEDNAX

MEDNAX, Inc., is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, the Company expanded into anesthesia services. Today, American Anesthesiology includes more than 750 anesthesiologists and advanced practitioners. MEDNAX, through its affiliated professional corporations, employs more than 1,700 physicians in 34 states and Puerto Rico. Additional information is available at www.mednax.com.

CONTACT:

MEDNAX, Inc.
David Parker, 954-384-0175, Ext. 5692
Vice President, Investor Relations & Corporate Communications
david_parker@mednax.com

KEYWORDS:   United States  North America  Florida

INDUSTRY KEYWORDS:   Practice Management  Health  Other Health  Nursing  General Health  Managed Care

MEDIA: